These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18449204)

  • 1. Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo.
    Shammas MA; Koley H; Bertheau RC; Neri P; Fulciniti M; Tassone P; Blotta S; Protopopov A; Mitsiades C; Batchu RB; Anderson KC; Chin A; Gryaznov S; Munshi NC
    Leukemia; 2008 Jul; 22(7):1410-8. PubMed ID: 18449204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
    Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL
    Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor.
    Dikmen ZG; Gellert GC; Jackson S; Gryaznov S; Tressler R; Dogan P; Wright WE; Shay JW
    Cancer Res; 2005 Sep; 65(17):7866-73. PubMed ID: 16140956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma.
    Hu Y; Bobb D; He J; Hill DA; Dome JS
    Cancer Biol Ther; 2015; 16(6):949-57. PubMed ID: 25920748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
    Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS
    Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
    Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer.
    Gellert GC; Dikmen ZG; Wright WE; Gryaznov S; Shay JW
    Breast Cancer Res Treat; 2006 Mar; 96(1):73-81. PubMed ID: 16319992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel.
    Goldblatt EM; Gentry ER; Fox MJ; Gryaznov SM; Shen C; Herbert BS
    Mol Cancer Ther; 2009 Jul; 8(7):2027-35. PubMed ID: 19509275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiadhesive effects of GRN163L--an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase.
    Jackson SR; Zhu CH; Paulson V; Watkins L; Dikmen ZG; Gryaznov SM; Wright WE; Shay JW
    Cancer Res; 2007 Feb; 67(3):1121-9. PubMed ID: 17283146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligonucleotide conjugate GRN163L targeting human telomerase as potential anticancer and antimetastatic agent.
    Gryaznov SM; Jackson S; Dikmen G; Harley C; Herbert BS; Wright WE; Shay JW
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1577-9. PubMed ID: 18066830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
    Akiyama M; Hideshima T; Shammas MA; Hayashi T; Hamasaki M; Tai YT; Richardson P; Gryaznov S; Munshi NC; Anderson KC
    Cancer Res; 2003 Oct; 63(19):6187-94. PubMed ID: 14559802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid modification of GRN163, an N3'-->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition.
    Herbert BS; Gellert GC; Hochreiter A; Pongracz K; Wright WE; Zielinska D; Chin AC; Harley CB; Shay JW; Gryaznov SM
    Oncogene; 2005 Aug; 24(33):5262-8. PubMed ID: 15940257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells.
    Burchett KM; Yan Y; Ouellette MM
    PLoS One; 2014; 9(1):e85155. PubMed ID: 24409321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.
    Shammas MA; Qazi A; Batchu RB; Bertheau RC; Wong JY; Rao MY; Prasad M; Chanda D; Ponnazhagan S; Anderson KC; Steffes CP; Munshi NC; De Vivo I; Beer DG; Gryaznov S; Weaver DW; Goyal RK
    Clin Cancer Res; 2008 Aug; 14(15):4971-80. PubMed ID: 18676772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imetelstat (a telomerase antagonist) exerts off‑target effects on the cytoskeleton.
    Mender I; Senturk S; Ozgunes N; Akcali KC; Kletsas D; Gryaznov S; Can A; Shay JW; Dikmen ZG
    Int J Oncol; 2013 May; 42(5):1709-15. PubMed ID: 23545855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma.
    Duus J; Bahar HI; Venkataraman G; Ozpuyan F; Izban KF; Al-Masri H; Maududi T; Toor A; Alkan S
    Leuk Lymphoma; 2006 Jul; 47(7):1369-78. PubMed ID: 16923571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase targeted oligonucleotide thio-phosphoramidates in T24-luc bladder cancer cells.
    Dikmen ZG; Wright WE; Shay JW; Gryaznov SM
    J Cell Biochem; 2008 May; 104(2):444-52. PubMed ID: 18044713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
    Manni S; Brancalion A; Tubi LQ; Colpo A; Pavan L; Cabrelle A; Ave E; Zaffino F; Di Maira G; Ruzzene M; Adami F; Zambello R; Pitari MR; Tassone P; Pinna LA; Gurrieri C; Semenzato G; Piazza F
    Clin Cancer Res; 2012 Apr; 18(7):1888-900. PubMed ID: 22351691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
    Shammas MA; Shmookler Reis RJ; Akiyama M; Koley H; Chauhan D; Hideshima T; Goyal RK; Hurley LH; Anderson KC; Munshi NC
    Mol Cancer Ther; 2003 Sep; 2(9):825-33. PubMed ID: 14555701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of telomerase template antagonist GRN163L on bone-marrow-derived rat mesenchymal stem cells is reversible and associated with altered expression of cyclin d1, cdk4 and cdk6.
    Tokcaer-Keskin Z; Dikmen ZG; Ayaloglu-Butun F; Gultekin S; Gryaznov SM; Akcali KC
    Stem Cell Rev Rep; 2010 Jun; 6(2):224-33. PubMed ID: 20180048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.